Paul Soloway,
Professor
Paul Soloway earned a BA in Biochemistry from Cornell, a PhD in Molecular Genetics from Princeton and performed post doctoral studies at MIT and the Whitehead Institute. He was a Research Scientist at Roswell Park Cancer Institute before joining the Cornell University faculty where he is studying mechanisms regulating placement of epigenetic marks in the genome and is developing single molecule approaches for multiplexed epigenomic analysis. Dr. Soloway is co-founder of Odyssey Molecular, a company that seeks to commercialize next generation epigenomic technologies for academic, drug development and clinical applications.
|
|
|
